litlas
ログインアカウント作成

William S. Dalton

1976–2024 年に発表

106
論文数
26,380
被引用数
85
h 指数
104
i10 指数

被引用数

William S. Dalton の年別被引用数1948 年: 被引用 1 件1981 年: 被引用 1 件1982 年: 被引用 1 件1986 年: 被引用 3 件1987 年: 被引用 3 件1988 年: 被引用 9 件1989 年: 被引用 18 件1990 年: 被引用 28 件1991 年: 被引用 55 件1992 年: 被引用 48 件1993 年: 被引用 46 件1994 年: 被引用 42 件1995 年: 被引用 83 件1996 年: 被引用 89 件1997 年: 被引用 70 件1998 年: 被引用 60 件1999 年: 被引用 131 件2000 年: 被引用 208 件2001 年: 被引用 242 件2002 年: 被引用 256 件2003 年: 被引用 297 件2004 年: 被引用 246 件2005 年: 被引用 247 件2006 年: 被引用 298 件2007 年: 被引用 313 件2008 年: 被引用 285 件2009 年: 被引用 308 件2010 年: 被引用 315 件2011 年: 被引用 309 件2012 年: 被引用 281 件2013 年: 被引用 349 件2014 年: 被引用 279 件2015 年: 被引用 248 件2016 年: 被引用 237 件2017 年: 被引用 164 件2018 年: 被引用 193 件2019 年: 被引用 530 件2020 年: 被引用 561 件2021 年: 被引用 545 件2022 年: 被引用 317 件2023 年: 被引用 238 件2024 年: 被引用 303 件2025 年: 被引用 135 件2026 年: 被引用 3 件1949〜1980 年は被引用が無いため表示していません1983〜1985 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,368 件、この内訳の 33.8%中国: 引用元論文 878 件、この内訳の 8.8%ドイツ: 引用元論文 552 件、この内訳の 5.5%イタリア: 引用元論文 488 件、この内訳の 4.9%イギリス: 引用元論文 484 件、この内訳の 4.9%フランス: 引用元論文 376 件、この内訳の 3.8%オランダ: 引用元論文 340 件、この内訳の 3.4%カナダ: 引用元論文 329 件、この内訳の 3.3%日本: 引用元論文 297 件、この内訳の 3%スペイン: 引用元論文 267 件、この内訳の 2.7%オーストラリア: 引用元論文 222 件、この内訳の 2.2%インド: 引用元論文 173 件、この内訳の 1.7%
0%33.8%その他 22%

機関

分野

  • Medicine59.3%
  • Biochemistry, Genetics and Molecular Biology29.9%
  • Immunology and Microbiology5.5%
  • Engineering0.9%
  • Materials Science0.7%
  • Mathematics0.7%
  • その他3%

トピック

  • Multiple Myeloma Research and Treatments5.8%
  • Cytokine Signaling Pathways and Interactions3.7%
  • Drug Transport and Resistance Mechanisms3.4%
  • Protein Degradation and Inhibitors2.9%
  • MicroRNA in disease regulation2.7%
  • Ubiquitin and proteasome pathways2.1%
  • その他79.4%

共著者

全論文

検索で開く
  1. Environment-mediated drug resistance: a major contributor to minimal residual disease

    著者: Mark B. Meads, Robert A. Gatenby, William S. Dalton - Nature reviews. Cancer 2009 被引用: 864

  2. A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study

    著者: Jacob G. Scott, Anders Berglund, Michael J. Schell, I Mihaylov, William J. Fulp, Binglin Yue, Eric A. Welsh, Jimmy J. Caudell, Kamran A. Ahmed, T. Ström, Eric A. Mellon, Puja Venkat, Peter A.S. Johnstone, John A. Foekens, Jae Lee, Eduardo G. Moros, William S. Dalton, Steven A. Eschrich, Howard L. McLeod, Louis B. Harrison, Javier F. Torres–Roca - The Lancet Oncology 2016 被引用: 469

  3. Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells

    著者: Tianhong Wang, Guilian Niu, Marcin Kortylewski, Lyudmila G. Burdelya, Kenneth H. Shain, Shumin Zhang, Raka Bhattacharya, Dmitry I. Gabrilovich, Richard Heller, Domenico Coppola, William S. Dalton, Richard Jove, Drew M. Pardoll, Hua Yu - Nature Medicine 2003 被引用: 1,148

  4. Bortezomib or High-Dose Dexamethasone for Relapsed Multiple Myeloma

    著者: Paul G. Richardson, Pieter Sonneveld, Michael W. Schuster, David Irwin, Edward A. Stadtmauer, Thierry Façon, Jean‐Luc Harousseau, Dina Ben‐Yehuda, Sagar Lonial, Hartmut Goldschmidt, Donna Reece, Jesús F. San Miguel, Joan Bladé, Mario Boccadoro, Jamie Cavenagh, William S. Dalton, Anthony Boral, Dixie Esseltine, Jane Porter, David P. Schenkein, Kenneth C. Anderson - New England Journal of Medicine 2005 被引用: 2,493

  5. MicroRNA-155 Is Regulated by the Transforming Growth Factor β/Smad Pathway and Contributes to Epithelial Cell Plasticity by Targeting RhoA

    著者: William Kong, Hua Yang, Lili He, Jianjun Zhao, Domenico Coppola, William S. Dalton, Jin Q. Cheng - Molecular and Cellular Biology 2008 被引用: 689

  6. Constitutive Activation of Stat3 Signaling Confers Resistance to Apoptosis in Human U266 Myeloma Cells

    著者: Robyn Catlett-Falcone, Terry H. Landowski, Marc M. Oshiro, James Turkson, Alexander Levitzki, Rocco Savino, Gennaro Ciliberto, Lynn C. Moscinski, José L. Fernández-Luna, Gabriel Núñez, William S. Dalton, Richard Jove - Immunity 1999 被引用: 1,651

  7. Optimizing Cancer Treatment Using Game Theory

    著者: Kateřina Staňková, Joel S. Brown, William S. Dalton, Robert A. Gatenby - JAMA Oncology 2018 被引用: 216

  8. Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study

    著者: Shaji Kumar, J H Lee, Juan José Lahuerta, Gareth J. Morgan, Paul G. Richardson, John Crowley, J. Haessler, J Feather, Antje Hoering, Philippe Moreau, Xavier Leleu, Cyrille Hulin, Saskia K. Klein, Pieter Sonneveld, David S. Siegel, Joan Bladé, Hartmut Goldschmidt, Sundar Jagannath, Jesús F. San Miguel, Robert Z. Orlowski, Antonio Palumbo, Orhan Sezer, S. Vincent Rajkumar, Brian G.M. Durie, on behalf of the International Myeloma Working Group, International Myeloma Working Group, Niels Abildgaard, Rafat Abonour, R. Alexanian, Melissa Alsina, C Anderson Kenneth, Michael Attal, Hervé Avet‐Loiseau, Ashraf Badros, Dalsu Baris, Bart Barlogie, Régis Bataille, Meral Beksaç, Andrew Belch, Dina Ben‐Yehuda, Bill Bensinger, P. Leif Bergsagel, Jenny Bird, Joan Bladé, Mario Boccadoro, Michèle Cavo, Asher Chanan‐Khan, Wen Ming Chen, Tony Child, James Chim, Wee Joo Chng, Ray Comenzo, John Crowley, William S. Dalton, Faith E. Davies, Cármino Antônio De Souza, Michel Delforge, Meletios Α. Dimopoulos, Angela Dispenzieri, Johannes Drach, Matthew T. Drake, Brian G.M. Durie, Hermann Einsele, Theirry Facon, Dorotea Fantl, Jean‐Paul Fermand, Rafaël Fonseca, Gösta Gahrton, Ramón García‐Sánz, Christina Gasparetto, Morie A. Gertz, John Gibson, Sergio Giralt, Hartmut Goldschmidt, Philip R. Greipp, Roman Hájek, Izhar Hardan, Parameswaran Hari, Jean‐Luc Harousseau, Hiroyuki Hata, Yutaka Hattori, Tom Heffner, Joy Ho, Vânia Hungria, Shinsuke Ida, Peter Jacob, Sundar Jagannath, Hans Erik Johnsen, Jian Hou, Douglas Joshua, Artur Jurczyszyn, Michio Kawano, Nicolaus Kröger, Shaji Kumar, Robert A. Kyle, Martha Q. Lacy, Juan José Lahuerta, Ola Landgren, Jacob P. Laubach, Jae Hoon Lee ほか 60 名 - Leukemia 2011 被引用: 721

  9. Unification of de novo and acquired ibrutinib resistance in mantle cell lymphoma

    著者: Xiaohong Zhao, Tint Lwin, Ariosto Silva, Bijal Shah, Jiangchuan Tao, Bin Fang, Liang Zhang, Kai Fu, Chengfeng Bi, Jiannong Li, Huijuan Jiang, Mark B. Meads, Timothy Jacobson, Maria João Silva, Allison Distler, Lancia Darville, Ling Zhang, Ying Han, Dmitri Rebatchouk, Maurizio Di Liberto, Lynn C. Moscinski, John M. Koomen, William S. Dalton, Kenneth H. Shain, Michael Wang, Eduardo M. Sotomayor, Jianguo Tao, Jianguo Tao, Jianguo Tao - Nature Communications 2017 被引用: 148

  10. The Bone Marrow Microenvironment as a Tumor Sanctuary and Contributor to Drug Resistance

    著者: Mark B. Meads, Lori Hazlehurst, William S. Dalton - Clinical Cancer Research 2008 被引用: 520

  11. ABCG2 expression, function, and promoter methylation in human multiple myeloma

    著者: Joel G. Turner, Jana Gump, Chunchun Zhang, James M. Cook, Douglas C. Marchion, Lori Hazlehurst, Pamela N. Münster, Michael J. Schell, William S. Dalton, Daniel M. Sullivan - Blood 2006 被引用: 188

  12. Vaults Are Up-regulated in Multidrug-resistant Cancer Cell Lines

    著者: Valerie A. Kickhoefer, Kavitha S. Rajavel, George L. Scheffer, William S. Dalton, Rik J. Scheper, Leonard H. Rome - Journal of Biological Chemistry 1998 被引用: 254

  13. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.

    著者: Robert H. Collins, Ofer Shpilberg, William R. Drobyski, David Porter, Sergio Giralt, Richard E. Champlin, Stacey Goodman, S N Wolff, Hu Wh, Catherine M. Verfaillie, Alan F. List, William S. Dalton, Nadine Ognoskie, Angela Chetrit, Joseph H. Antin, John Nemunaitis - Journal of Clinical Oncology 1997 被引用: 1,258

  14. Jagged2 targeting in lung cancer activates anti-tumor immunity via Notch-induced functional reprogramming of tumor-associated macrophages

    著者: Jay K. Mandula, Rosa A. Sierra-Mondragon, Rachel V. Jimenez, Darwin Chang, Eslam Mohamed, Shiun Chang, Julio Angel Vázquez-Martínez, Yu Cao, Carmen M. Anadon, Sae Bom Lee, Satyajit Das, Léo Rocha-Munguba, Vincent Pham, Roger Li, Ahmad A. Tarhini, Muhammad Furqan, William S. Dalton, Michelle L. Churchman, Carlos Moran Segura, Jonathan V. Nguyen, Bradford A. Perez, Douglas J. Kojetin, Alyssa Obermayer, Xiaoqing Yu, Ann Chen, Timothy I. Shaw, José R. Conejo-García, Paulo C. Rodrı́guez - Immunity 2024 被引用: 32

  15. Cell Adhesion Mediated Drug Resistance (CAM-DR): Role of Integrins and Resistance to Apoptosis in Human Myeloma Cell Lines

    著者: Jason S. Damiano, Anne E. Cress, Lori Hazlehurst, Аlexander А. Shtil, William S. Dalton - Blood 1999 被引用: 865

  16. PLK1 stabilizes a MYC-dependent kinase network in aggressive B cell lymphomas

    著者: Yuan Ren, Chengfeng Bi, Xiaohong Zhao, Tint Lwin, Cheng Wang, Yuan Ji, Ariosto S. Silva, Bijal Shah, Bin Fang, Tao Li, John M. Koomen, Huijuan Jiang, Julio C. Chávez, Lan V. Pham, Praneeth Sudalagunta, Lixin Wan, Xuefeng Wang, William S. Dalton, Lynn C. Moscinski, Kenneth H. Shain, Julie M. Vose, John L. Cleveland, Eduardo M. Sotomayor, Kai Fu, Jianguo Tao - Journal of Clinical Investigation 2018 被引用: 92

  17. Phase III study of PSC‐833 (valspodar) in combination with vincristine, doxorubicin, and dexamethasone (valspodar/VAD) versus VAD alone in patients with recurring or refractory multiple myeloma (E1A95)

    著者: William R. Friedenberg, Montserrat Rué, Emily Blood, William S. Dalton, Chaim Shustik, Richard A. Larson, Pieter Sonneveld, Philip R. Greipp - Cancer 2006 被引用: 163

  18. The FA/BRCA pathway is involved in melphalan-induced DNA interstrand cross-link repair and accounts for melphalan resistance in multiple myeloma cells

    著者: Qing Chen, Pieter C. Van der Sluis, David Boulware, Lori Hazlehurst, William S. Dalton - Blood 2005 被引用: 141

  19. Adhesion to fibronectin via β1 integrins regulates p27kip1 levels and contributes to cell adhesion mediated drug resistance (CAM-DR)

    著者: Lori Hazlehurst, Jason S. Damiano, I Buyuksal, W. J. Pledger, William S. Dalton - Oncogene 2000 被引用: 342

  20. Gene therapy with dominant-negative Stat3 suppresses growth of the murine melanoma B16 tumor in vivo.

    著者: Gang Niu, Richard Heller, Robyn Catlett-Falcone, Domenico Coppola, Mark J. Jaroszeski, William S. Dalton, Richard Jove, Hua Yu - 1999 被引用: 315

  21. Methylation of Discrete Regions of the O 6 -Methylguanine DNA Methyltransferase (MGMT) CpG Island Is Associated with Heterochromatinization of the MGMT Transcription Start Site and Silencing of the Gene

    著者: George S. Watts, Russell O. Pieper, J Costello, Yei-Mei Peng, William S. Dalton, Bernard W. Futscher - Molecular and Cellular Biology 1997 被引用: 218

  22. Cell adhesion-mediated drug resistance (CAM-DR) is associated with activation of NF-κB (RelB/p50) in myeloma cells

    著者: Terry H. Landowski, Nancy Olashaw, Deepak Agrawal, William S. Dalton - Oncogene 2003 被引用: 185

  23. Stemness of B-cell Progenitors in Multiple Myeloma Bone Marrow

    著者: Kelly Boucher, Nancy Parquet, Raymond Widen, Kenneth H. Shain, Rachid Baz, Melissa Alsina, John M. Koomen, Claudio Anasetti, William S. Dalton, Lia Perez - Clinical Cancer Research 2012 被引用: 85

  24. Treatment of acquired drug resistance in multiple myeloma by combination therapy with XPO1 and topoisomerase II inhibitors

    著者: Joel G. Turner, Jana L. Dawson, Steven Grant, Kenneth H. Shain, William S. Dalton, Yun Dai, Mark B. Meads, Rachid Baz, Michael Kauffman, Sharon Shacham, Daniel M. Sullivan - Journal of Hematology & Oncology 2016 被引用: 84